Monday, April 9, 2012
The 2009 RV144, or Thai AIDS vaccine trial, was the proverbial half-full glass. The vaccine did confer protection against AIDS; but at about 30 percent risk reduction, the vaccine was not effective enough to justify its further development.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.